Vanguard Group Inc Acrivon Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 637,538 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
637,538
Previous 745,510 14.48%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
N/A
-107,972 Reduced 14.48%
637,538 $0
Q2 2024

Aug 13, 2024
BUY
N/A
238,325 Added 46.99%
745,510 $0
Q1 2024

May 10, 2024
BUY
N/A
31,208 Added 6.56%
507,185 $0
Q4 2023

Feb 14, 2024
BUY
N/A
7,570 Added 1.62%
475,977 $0
Q3 2023

Nov 14, 2023
BUY
N/A
65,132 Added 16.15%
468,407 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-5,940 Reduced 1.45%
403,275 $0
Q1 2023

May 15, 2023
BUY
N/A
409,215 New
409,215 $0

Others Institutions Holding ACRV

# of Institutions
53
Shares Held
23.2M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email